What do its site and FDA’s records show?
| Website | Not found |
| FDA warning letters on GLP-1 drugs | 1 |
What did FDA write to Intimate Rose?
On September 9, 2025 FDA sent Intimate Rose a warning letter under the subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”. It quotes the site, for example: Same active ingredient as Ozempic and Wegovy.
Read the facts and the full text of the letter.
Is the price I was quoted high or low?
Enter a monthly price. The chart places it among the lowest monthly prices that 297 sellers show on their own sites.
Which sellers show a lower price and have no FDA letter?
245 sellers in our database name the same drugs, show a lower monthly price and have no FDA warning letter about GLP-1 drugs. The six lowest:
The lowest price a site shows is often a first month, a membership fee or the smallest dose; read the sentence on each seller’s page before comparing.
How can I check Intimate Rose myself?
- Look the pharmacy up. A compounded GLP-1 is filled by a pharmacy, not by the telehealth company; ask which one, and check its license with the state board of pharmacy. FDA’s BeSafeRx page explains the warning signs of an unsafe online pharmacy.1
- Check certification yourself. A LegitScript badge on a site is not proof; LegitScript’s own lookup shows whether a website is certified.2
- Read what FDA says about compounded and unapproved GLP-1 drugs before paying for one.3
- Search the seller in our database of FDA warning letters.
Sources
- FDA. BeSafeRx: your source for online pharmacy information. fda.gov
- LegitScript. Website certification status lookup. legitscript.com
- FDA. Concerns with unapproved GLP-1 drugs used for weight loss. fda.gov
- FDA. Warning letter to Intimate Rose, September 9, 2025. Dose Insider summary with the link to fda.gov
Log every dose in mg with the vial it came from, so there is a record if something goes wrong.
Open Dose Insider